SYRE Cash Ratio

Spyre Therapeutics Inc · Cash Ratio

SYRE logo

SYRE Cash Ratio

Current (TTM)2.56
SYRE Cash Ratio (3.26 → 2.56)
High-resolution chart · PNG

SYRE cash ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cash Ratio — Annual fiscal periods
Period endingCash Ratio
1.4607
1.6541
5.907
2.3788
0.7517
5.4792
1.0487
2.1937
2.277
12.0424
11.6108
2.4726
3.2557
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.